Abstract Purpose The impact of programs, policies, and practices developed by professionals in the field of maternal and child health (MCH) epidemiology is highlighted biennially by 16 national MCH agencies and organizations, or the Coalition for Excellence in MCH Epidemiology. Description In September 2014, multiple leading agencies in the field of MCH partnered to host the national CityMatCH Leadership and MCH Epidemiology Conference in Phoenix, Arizona. The conference offered opportunities for peer exchange; presentation of new scientific methodologies, programs, and policies; dialogue on changes in the MCH field; and discussion of emerging MCH issues relevant to the work of local, state, and national MCH professionals. During the conference, the National MCH Epidemiology Awards were presented to individuals, teams, institutions, and leaders for significantly contributing to the improved health of women, children, and families. Assessment During the conference, the Coalition presented seven deserving health researchers and research groups with national awards in the areas of advancing knowledge, effective practice, outstanding leadership, young professional achievement, and lifetime achievement. The article highlights the accomplishments of these national-level awardees. Conclusion Recognition of deserving professionals strengthens the field of MCH epidemiology, and sets the standard for exceptional research, mentoring, and practice.
promoting excellence in the field of MCH epidemiology. The purpose of the national awards is to highlight contributions to MCH in the following four categories:
1. Advancing public health knowledge through MCH epidemiology and applied research; 2. Improving public health practice through the effective use of MCH data and epidemiology; 3. Strengthening MCH public health practice through excellence in teaching, mentoring, and training in the use of data, epidemiologic methods, and applied research; and 4. Providing leadership to enhance the political will to advance public health knowledge and practice and the effective use of MCH data, epidemiology, and applied research.
Description
Awards are presented biennially in six categories, including advancing knowledge, effective practice, outstanding leadership, excellence in teaching and mentoring, young professional achievement, and lifetime achievement. Award recipients are nominated by peers, nominations are reviewed, and awardees are selected by the National MCH Epidemiology Awards Selection Committee, comprised of members of the Coalition. To be eligible for nomination, MCH professionals must publish or work in the field of MCH in the United States. The work of each nominee may represent independent scientific research and collaborative applied public health activities. Both individual and group nominations are acceptable. Previous award recipients are listed in Table 2 .
Assessment
To Health at the University of British Columbia in Vancouver, Canada. With over 150 peer-reviewed publications, Dr. Joseph has distinguished himself as one of the leading perinatal and MCH epidemiologists in the field. Over a career spanning more than 25 years, one of Dr. Joseph's main accomplishments is his seminal work on understanding the increasing trend in preterm birth rates that began in the 1980s across North America and other developing countries. His finding that obstetrical interventions explained much of this trend resulted in the implementation of interventions to reduce elective deliveries prior to 37 weeks. The decrease in preterm induction of labor and cesarean deliveries from these interventions may have influenced recent declines in the U.S. preterm birth rate. In addition to his work on trends in preterm birth, Dr. Joseph has conducted epidemiologic research on neonatal mortality among preterm infants, with a particular focus on the importance of gestational age measurement. His research comparing infant mortality rates between the U.S. and Canada demonstrated that the country-specific rates varied depending on which gestational age measurement was used. As a result, the obstetrical estimate of gestational age is now considered the standard measure to use when analyzing perinatal outcomes in vital records data. Dr. Joseph was also one of the first researchers to shed light on the ''birth weight paradox'' and suggested using a fetusesat-risk approach to assess neonatal mortality rather than analyzing live births. His work uncovered pathological underpinnings to the observed birthweight-for-gestational age distributions among black and firstborn infants, thus suggesting that race and parity-specific growth standards were unnecessary. Additionally, with his interest in maternal health, Dr. Joseph has published research on trends and risk factors for postpartum hemorrhage, amniotic fluid embolism, and eclampsia.
Dr. Joseph's contributions through epidemiology and applied research have advanced public health knowledge pertaining to the health and wellbeing of mothers and infants around the world. He has challenged existing paradigms and changed our understanding of important issues in MCH epidemiology and is deserving of the Greg Alexander Award for Advancing Knowledge.
Award for Effective Practice at the National Level: Improving Public Health Practice Through Effective Use of Data, Epidemiology, and Applied Research Marian MacDorman, PhD Dr. Marian MacDorman has contributed to national public health efforts for more than 25 years. She has been successful at fulfilling both her government role and reporting responsibilities while also developing a national research With a background in both geography and demography, Dr. MacDorman has initiated novel research in MCH while utilizing a variety of national datasets, including fetal death records and linked birth and infant death records. As a result, she has published numerous articles, statistical reports, and NCHS data briefs. In the past 5 years alone, Dr. MacDorman has been the lead or contributing author on over 10 statistical reports and more than 15 peer-reviewed articles. Some of her most noteworthy work focused on the association between obstetrical interventions and preterm birth rates in the U.S. Her findings that prematurity rates were decreasing among spontaneous vaginal births and increasing among those with obstetrical interventions were published in the American Journal of Public Health. This research has also provided evidence to support state and national efforts to prevent elective deliveries prior to 39 weeks of gestation. In 2007, Dr. MacDorman's collaborative work on the development of a new measure of low risk cesarean deliveries and related birth outcomes was deemed as one of the 100 most important articles by Science Magazine.
Dr. MacDorman is nationally recognized for her contributions to the MCH field. Her commitment to public service and use of epidemiological methods to advance the health of mothers and children in the U.S. are clear examples of effective practice in MCH epidemiology at the national level. Dr. Cohen's public health career includes seminal work in assessing maternal and fetal outcomes following the use of assisted reproductive technology (ART). As the principal investigator of a multi-state linkage project of vital records and CDC's ART surveillance system, Dr. Cohen identified important risk factors and perinatal outcomes associated with ART. He and his colleagues published several articles on the findings from this research between 2006 and 2014. Dr. Cohen has also led the development, facilitation, and promotion of core principles for the expansion of standards for classifying data on race, ethnicity, and primary language. These data extended beyond the Office of Management and Budget standard to provide more detailed, self-reported information. As a result of his efforts, Massachusetts implemented more extensive racial and ethnic classifications that are used for a variety of health initiatives.
Award for Effective Practice at the
In addition to his research, Dr. Cohen has been instrumental in developing initiatives to promote the maintenance of individual privacy and confidentiality pertaining to vital records data. Under his leadership as Chair of the NAPHSIS Statistics and Research Review committee and in collaboration with the National Center for Health Statistics, states have been given the opportunity to review and approve data requests for vital records from over 500 researcher-initiated applications. Dr. Cohen has also been involved in the development of standardized agreements to release selected national data for public health surveillance while assuring the protection of respondent confidentiality of birth and death data. Given Dr. Cohen's contributions to state-level initiatives in Massachusetts and elsewhere, his work exemplifies effective practice at the state level.
Award for Effective Practice at the State Level: Improving Public Health Practice Through Effective Use of Data, Epidemiology, and Applied Research The Massachusetts Pregnancy to Early Life Longitudinal (PELL) Data System Team
The Massachusetts PELL data system, a population-based, relational, reproductive and child health system, was developed through a collaborative public-university partnership between the Boston University School of Public Health, Massachusetts Department of Public Health, and the CDC. This data system utilizes a broad range of public health data (e.g., live birth and fetal death certificates, hospital discharge records, program data) to assess the ongoing impact of the prenatal environment on MCH populations. Since 1998, the PELL system has included data on more than 1,000,000 live births and 5200 fetal deaths, including approximately 265,000 sequential deliveries occurring in Massachusetts.
The PELL system, through its longitudinal linkage of data from multiple sources, provides a unique opportunity to examine social determinants of health, identify health disparities, and assess health services among women and children in Massachusetts. As a result, the PELL data system team has contributed greatly to the MCH field through a variety of activities, including: (1) providing data to inform the development of MCH programs and policies; (2) providing data for epidemiologic research of critical issues in MCH; (3) educating providers and the public about important findings from epidemiologic research and evaluation; (4) improving referral to and delivery of appropriate services for women and children in Massachusetts; and (5) improving the quality of clinical care for MCH populations.
The initiatives undertaken by the multidisciplinary group of PELL collaborators have been successful at improving the use of data to inform MCH programs and policies for the state of Massachusetts. For example, the group has been involved in evaluating the Massachusetts Early Intervention program, improving identification of children with autism spectrum disorders, and reducing early elective deliveries and unnecessary obstetrical interventions. PELL serves as a model for other states. Through over 100 trainings and presentations and more than 20 peer-reviewed publications, the PELL team has encouraged other states to build data capacity and develop data systems to assess critical MCH issues. For their work in improving public health practice through the effective use of data and training of the MCH field, the PELL data system team provides a commendable example of Effective Practice at the State level. For many years, Dr. Allen has promoted the use of data to inform programs and policies, and to educate the public about the health status of MCH populations in Boston. As a result, the city of Boston has been a leader in local MCH efforts. The success of these efforts as well as other initiatives has been largely driven by Dr. Allen's partnership with the BPHC Office of Research and Evaluation. For example, the first ever citywide survey of children's health based off of the National Survey of Children's Health was implemented in the city of Boston in 2012. In addition, this partnership aided in the reorganization of the BPHC perinatal data systems to facilitate the promotion of centering pregnancy, a type of group care for pregnant women.
Dr. Allen also advocates for using data to identify and address health disparities and inequities in public health. In collaboration with her colleagues from the Office of Research and Evaluation, Dr. Allen has conducted research to assess factors contributing to the racial disparities in gestational length among black and white infants in Boston, and to better understand why these inequalities increase with shorter gestational length. These activities and many others under Dr. Allen's leadership have made a lasting impact on the MCH population in Boston, thus making her the ideal candidate for the 2014 Outstanding Leader award.
Award for Young Professional Achievement Susanna Visser, MS, DrPH
Dr. Susanna Visser is the acting Associate Director of Science in the Division of Human Development and Disability at the CDC National Center on Birth Defects and Developmental Disabilities. She began working at the CDC in 2001 and her research focuses primarily on neurobehavioral and mental health conditions of children. She currently directs CDC's programmatic efforts related to attention-deficit/hyperactivity disorder (ADHD).
During her career thus far, Dr. Visser has made important contributions to the MCH field. Her seminal work on ADHD has provided national estimates of parent-reported medication use for ADHD, and both national and state-level estimates of trends in parent-reported ADHD, none of which have been previously reported. Dr. Visser has authored or coauthored more than 25 articles, several of which describe the factors associated with medication treatment for childhood ADHD. Her work has been used to inform state-level investigations of behavioral health among children.
In addition to conducting research, Dr. Visser is actively involved in moving data to action. The American Academy of Pediatrics (AAP) as well as federal and state agencies have used Dr. Visser's groundbreaking work on ADHD to inform health policies and practices for children. Dr. Visser served as the leading epidemiologist on the AAP committee for the ADHD Diagnostic and Treatment Guidelines. Her work pertaining to childhood ADHD has also been used by the Food and Drug Administration during an investigation regarding the increase in cardiovascular events among children using medication for ADHD. Specifically, Dr. Visser's population-based estimates were used to estimate the prevalence of stroke, myocardial infarction, and other cardiovascular events among children using medication for ADHD. Dr. Visser has helped build state-level data capacity by collaborating with state mental health program directors and leveraging data from the National Survey of Children's Health and other state-based data systems to examine state-level trends in ADHD and to provide a comprehensive examination of related factors.
Dr. Visser's contributions to the MCH field, particularly with the use of data to inform programs and policies for children with ADHD, have led to her recognition as a national leader in MCH Epidemiology. Dr. Rogan's career includes seminal work on the effect of polychlorinated biphenyls (PCB) on child health, particularly his work on PCBs among children in Taiwan. In this study, children exposed to PCB in utero and an unexposed group of matched neighborhood controls were followed prospectively to assess their physical growth, behaviors, and development using clinical and psychometric assessments. The findings from this research were first published in Science and have been cited more than 400 times. Dr. Rogan's work has also been instrumental in informing public health policy and has generated an entire field devoted to assessing the impact of antenatal and childhood exposures to persistent organic pollutants on child health. His groundbreaking research on breastfeeding and environmental toxicants has been published in more than 20 articles.
Additionally, Dr. Rogan has been actively involved in promoting MCH policy. Dr. Rogan's many accomplishments in children's environmental health over the span of several decades have made important contributions to the MCH field. By using data to inform knowledge and health policy, he has had a lasting impact on the lives of women and children, epitomizing the meaning of the lifetime achievement award.
Conclusion
The Coalition for Excellence in MCH Epidemiology will convene to select the 2016 awardees in the summer of 2016. The awardees will be announced at the National MCH Epidemiology Awards Luncheon at the 2016 CityMatCH Leadership and MCH Epidemiology Conference to be held in Philadelphia, Pennsylvania on September 15, 2016. The nomination announcement for the 2016 National MCH Epidemiology Awards will occur in January of 2016 and applications will be due by April 15, 2016.
The National MCH Epidemiology Awards are an opportunity for professional recognition of notable accomplishments in the field of MCH. Acknowledging the accomplishments of these deserving awardees supports on-going work in the field, and provides an opportunity to disseminate the awards to a wider audience. To further recognize excellence in the field of MCH epidemiology, Coalition members urge readers to consider nomination of peers and colleagues to highlight their important accomplishments.
